Farmacia Hospitalaria y Farmacogenómica

Borras-Blasco J; Herráiz ER; Sánchez PL; Romero-Jimenez R; Navarro-Ruiz A; Sola NR.

Consensus of Spanish Society of Hospital Pharmacy on optimal medication therapy management of atopic dermatitis.

FARMACIA HOSPITALARIA. 2023; 47(4): 148-154 [doi:10.1016/j.farma.2023.03.007]

Beatriz, GC; Jose, OM; Ines, JL; Yolanda, HG; Concha, AD; Javier, TS; Cecilia, MFL.

Medication errors in children visiting pediatric emergency departments

FARMACIA HOSPITALARIA. 2023; 47(4): 141-147 Nº de citas: 8 [doi:10.1016/j.farma.2023.03.006]

Borras-Blasco, J; Herraiz, ER; Sanchez, PL; Romero-Jimenez, R; Navarro-Ruiz, A; Sola, NR.

Consensus of Spanish Society of Hospital Pharmacy on optimal medication therapy management of atopic dermatitis

FARMACIA HOSPITALARIA. 2023; 47(4): 148-154 [doi:10.1016/j.farma.2023.05.007]

Gonzalez, CGR; de Vega, EC; Martinez, SD; Minero, MV; Urbon, JMG; Manzorro, AG; Martinez, EFD; Sacristan, SC; Santiago, EB; Alonso, AH; de Paredes, PMG; Saez, MS.

A critical view on the current use of daptomycin in Spain: The daptomise study

Journal of Infection and Public Health. 2023; 16(7): 1115-1122 Nº de citas: 1 [doi:10.1016/j.jiph.2023.05.008]

Escudero-Vilaplana, V; Collado-Borrell, R; Martinez-Sagrera, PG; Villanueva-Bueno, C; Revuelta-Herrero, JL; Gonzalez-Haba, E; Hoyo-Munoz, A; Gilarranz, YJ; Marzal-Alfaro, B; Herranz, A; Martin, M; Sanjurjo, M.

Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; 149(7): 2855-2882 Nº de citas: 4 [doi:10.1007/s00432-022-04172-1]

Palomino-Cabrera, R; Tejerina, F; Molero-Salinas, A; Ferris, M; Veintimilla, C; Catalan, P; Macias, GR; Alonso, R; Munoz, P; de Viedma, DG; Perez-Lago, L.

Frequent Emergence of Resistance Mutations Following Complex Intra-Host Genomic Dynamics in SARS-CoV-2 Patients Receiving Sotrovimab

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2023; 67(7): Nº de citas: 6 [doi:10.1128/aac.00266-23]

Martin, MT; Boquet, EM; Aznares, HN; Cortes, MDR; Gonzalez, CR; de las Hazas, JISL; Morillo-Verdugo, R.

2022 update of the indicators for quality of care and pharmaceutical care for people living with human immunodeficiency virus

FARMACIA HOSPITALARIA. 2023; 47(3): 113-120 Nº de citas: 2 [doi:10.1016/j.farma.2023.01.007]

Conde, MTM; Boquet, EM; Aznares, HN; Cortes, MDR; Gonzalez, CR; de las Hazas, JISL; Morillo-Verdugo, R.

[Translated article] 2022 update of the indicators for quality of care and pharmaceutical care for people living with human immunodeficiency virus

FARMACIA HOSPITALARIA. 2023; 47(3): 113-120 [doi:10.1016/j.farma.2023.04.008]

Ruiz-Briones, P; Escudero-Vilaplana, V; Collado-Borrell, R; Vicente-Valor, J; Alvarez, R; Villanueva-Bueno, C; Narrillos-Moraza, A; Herranz, A; Sanjurjo, M.

Possible heart failure caused by osimertinib in a lung cancer patient

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2023; 29(4): 1015-1020 Nº de citas: 4 [doi:10.1177/10781552221143787]

Arhip, L; Camblor, M; Breton, I; Motilla, M; Serrano-Moreno, C; Romero, RM; Lobato, E; Frias, L; Velasco, C; Carrascal, ML; Cuerda, C.

Implementation of a parenteral nutrition home care programme in a tertiary hospital

NUTRICION HOSPITALARIA. 2023; 40(3): 476-484 [doi:10.20960/nh.04494]

Garcia-Martin, E; Romero-Jimenez, RM; Baniandres-Rodriguez, O; Escudero-Vilaplana, V; Benedi-Gonzalez, J; Luna, PMD; Herranz-Alonso, A; Sanjurjo-Saez, M.

Anti-interleukin-17 therapies for moderate/severe psoriasis in clinical practice: effectiveness, safety and association with clinical patient factors

EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023; 31(5): 409-415 Nº de citas: 2 [doi:10.1136/ejhpharm-2022-003594]

Garcia-Gonzalez, X; Cubo, E; Simon-Vicente, L; Mariscal, N; Alcaraz, R; Aguado, L; Rivadeneyra-Posadas, J; Sanz-Solas, A; Saiz-Rodriguez, M.

Thermodynamical Analysis of the Formation of a-Si Ring Structures on Silicon Surface

Journal Of Personalized Medicine. 2023; 13(3): Nº de citas: 7 [doi:10.3390/jpm13030385]

Villanueva-Bueno, C; Montecatine-Alonso, E; Jimenez-Parrilla, F; Gonzalez-Lopez, M; Manrique-Rodriguez, S; Moreno-Ramos, F; Canete-Ramirez, C; Dolz, E; Garcia-Robles, A; Caro-Teller, JM; Moral-Pumarega, MT; Bergon-Sendin, E; Calvo, MTGT; Gallego-Fernandez, C; del Vayo-Benito, CA; Mejias-Trueba, M; Gil-Navarro, MV.

Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice

Antibiotics-Basel. 2023; 12(3): Nº de citas: 2 [doi:10.3390/antibiotics12030602]

Laserna-Mendieta, EJ; Salvador-Martin, S; Arias, A; Lopez-Cauce, B; Marin-Jiminez, I; Menchen, LA; Marin-Rubio, L; Ontañón Rodríguez J; Lopez-Fernandez, LA; Lucendo, AJ.

Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C1 genes protect against infliximab failure in adults with Crohn?s disease

BIOMEDICINE & PHARMACOTHERAPY. 2023; 159: 114225-114225 Nº de citas: 10 [doi:10.1016/j.biopha.2023.114225]

De Castro, J; Insa, A; Collado-Borrell, R; Escudero-Vilaplana, V; Martinez, A; Fernandez, E; Sullivan, I; Arrabal, N; Carcedo, D; Manzaneque, A.

Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain

BMC Pulmonary Medicine. 2023; 23(1): Nº de citas: 6 [doi:10.1186/s12890-023-02356-0]

de la Villa, S; Herrero, S; Munoz, P; Rodriguez, C; Valerio, M; Reigadas, E; Alvarez-Uria, A; Alcala, L; Marin, M; Olmedo, M; Kestler, M; Chamorro, E; Bouza, E.

Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection

Open Forum Infectious Diseases. 2023; 10(2): Nº de citas: 7 [doi:10.1093/ofid/ofad028]

Torroba-Sanz, B; de Lorenzo-Pinto, A; Ribed-Sanchez, A; Martin-Barbero, ML; Gimenez-Manzorro, A; Garcia-Gonzalez, X; Ibanez-Garcia, S; Herranz-Alonso, A; Sanjurjo-Saez, M.

Achieving excellence in the pharmaceutical care of the surgical patient

FARMACIA HOSPITALARIA. 2023; 47(1): 26-30 Nº de citas: 1 [doi:10.1016/j.farma.2022.12.002]

Montecatine-Alonso, E; Mejias-Trueba, M; Goycochea-Valdivia, WA; Chavarri-Gil, E; Fernandez-Llamazares, CM; Dolz, E; Gutierrez-Urbon, JM; Gallego-Fernandez, C; Llorente-Gutierrez, J; Gil-Navarro, MV.

Development of Antimicrobial Defined Daily Dose (DDD) for the Pediatric Population

Antibiotics-Basel. 2023; 12(2): Nº de citas: 2 [doi:10.3390/antibiotics12020276]